Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples